Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study

J Infect. 2008 May;56(5):319-25. doi: 10.1016/j.jinf.2008.02.012. Epub 2008 Apr 10.

Abstract

Background: The aim of this study was to determine risk factors for relapse of ventilator-associated pneumonia (VAP) related to nonfermenting Gram negative bacilli (NF-GNB).

Methods: This is a retrospective case-control study based on prospectively collected data. Two hundred and seventy six patients with monobacterial VAP related to NF-GNB were eligible. Patients with subsequent superinfection or persistent pulmonary infection were excluded. Patients with relapse of NF-GNB VAP were matched (1:2) with patients without relapse. Matching criteria included the duration of mechanical ventilation before VAP relapse, age+/-5 years, SAPS II at ICU admission+/-5, and the date of admission. Univariate and multivariate analyses were used to determine risk factors for relapse of NF-GNB VAP in cases and controls.

Results: Thirty (10%) patients developed a relapse of NF-GNB VAP, 27 (90%) patients were successfully matched with 54 controls. Inappropriate initial antibiotic treatment was the only variable independently associated with relapse of VAP related to NF-GNB (OR [95% CI]=8.1 [2-33], p=0.003). Although ICU-mortality rate was similar in cases and controls (55% vs 72%, p=0.132), the duration of mechanical ventilation and ICU stay were significantly higher in cases than in controls.

Conclusion: Inappropriate initial antibiotic treatment is independently associated with relapse of VAP related to NF-GNB.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Case-Control Studies
  • Drug Resistance, Bacterial
  • Female
  • Gram-Negative Bacteria* / drug effects
  • Gram-Negative Bacteria* / isolation & purification
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / microbiology
  • Gram-Negative Bacterial Infections* / mortality
  • Gram-Negative Bacterial Infections* / prevention & control
  • Hospital Mortality
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pneumonia, Bacterial* / drug therapy
  • Pneumonia, Bacterial* / microbiology
  • Pneumonia, Bacterial* / mortality
  • Pneumonia, Bacterial* / prevention & control
  • Pneumonia, Ventilator-Associated* / drug therapy
  • Pneumonia, Ventilator-Associated* / microbiology
  • Pneumonia, Ventilator-Associated* / mortality
  • Pneumonia, Ventilator-Associated* / prevention & control
  • Recurrence
  • Respiration, Artificial
  • Risk Factors

Substances

  • Anti-Bacterial Agents